Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.8 USD
8.57%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Total Liabilities & Equity
|
Adaptive Biotechnologies Corp
Total Liabilities & Equity Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Total Liabilities & Equity
$620.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Liabilities & Equity
$98.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Liabilities & Equity
$83.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Liabilities & Equity
$3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Liabilities & Equity
$10.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Liabilities & Equity
$26.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
24%
|
See Also
What is Adaptive Biotechnologies Corp's Total Liabilities & Equity?
Total Liabilities & Equity
620.3m
USD
620.3m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Total Liabilities & Equity amounts to 620.3m USD.
What is Adaptive Biotechnologies Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
0%
0%
Over the last year, the Total Liabilities & Equity growth was -22%. The average annual Total Liabilities & Equity growth rates for Adaptive Biotechnologies Corp have been -17% over the past three years .
You don't have any saved screeners yet
